Livongo Health closed a $105 million round led by a group of investors including General Catalyst, Merck Global Health Innovation Fund and Echo Health Ventures.
The Mountain View, Calif.-based company has developed Livongo for Diabetes – a collection of connected devices that enable people with diabetes to interact with a virtual care team.
Get the full story at our sister site, Drug Delivery Business News.
The post Livongo raises $105m for digital diabetes management platform appeared first on MassDevice.
from MassDevice https://ift.tt/2HhS4rz
Cap comentari:
Publica un comentari a l'entrada